All Pathways
Emergency MedicineEmergency

Subarachnoid Hemorrhage Evaluation (ACEP 2019 + AHA 2023)

Subarachnoid Hemorrhage Evaluation (ACEP 2019 + AHA 2023): START: Suspected SAH → Clinical Assessment → Ottawa SAH Rule → Non-Contrast CT Head → CT Resu...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    START: Suspected SAH

    Sudden severe headache (thunderclap)

    1. Action

      Clinical Assessment

      High-risk features

      • Thunderclap headache (max intensity <1 min)
      • Worst headache of life
      • Neck stiffness/meningismus
      • Loss of consciousness, syncope
      • Focal neurologic deficit
      • Seizure at onset
      • Age >40 increases risk
      1. Action

        Ottawa SAH Rule

        Clinical decision tool

        • Consider SAH investigation if ANY present:
        • - Age ≥40
        • - Neck pain or stiffness
        • - Witnessed LOC
        • - Onset with exertion
        • - Thunderclap headache
        • - Limited neck flexion
        • 100% sensitive (validation ongoing)
        1. Action

          Non-Contrast CT Head

          First-line imaging

          • Sensitivity 95-100% within 6 hours
          • Decreases to 85% at 24h, 50% at 1 week
          • Modern CT scanners highly sensitive if interpreted by expert
          • Look for: Blood in cisterns, sulci, ventricles
          1. Decision

            CT Result?

            Interpret findings

            1. Warning

              CT Positive for SAH

              Blood identified on CT

              • Confirm SAH
              • Neurosurgery consult immediately
              • CTA to identify aneurysm source
              • Admit to ICU
              1. Action

                CT Angiography

                Identify aneurysm

                • 95-98% sensitivity for aneurysms >3mm
                • Identifies aneurysm location and morphology
                • May miss small aneurysms (<3mm)
                • DSA if CTA negative but high suspicion
                1. Action

                  SAH Management

                  Immediate interventions

                  • ICU admission
                  • BP control (SBP <160 before aneurysm secured)
                  • Nimodipine 60mg PO q4h x 21 days (reduces vasospasm)
                  • Secure aneurysm: Coiling vs clipping (within 24-72h)
                  • Monitor for vasospasm, hydrocephalus, rebleeding
            2. Decision

              CT Negative - LP Needed?

              Depends on timing and clinical suspicion

              • CT <6h + low suspicion: Some evidence LP may be deferred
              • CT >6h or high suspicion: LP recommended
              • Institutional protocols vary
              1. Action

                Lumbar Puncture

                CSF analysis

                • Collect 4 tubes
                • RBC count Tube 1 vs Tube 4 (traumatic tap clears)
                • Xanthochromia (visual or spectrophotometry)
                • Xanthochromia takes 12 hours to develop
                • Send for cell count, protein, glucose
                1. Decision

                  LP Result?

                  Interpret CSF

                  • POSITIVE: RBCs not clearing + xanthochromia
                  • NEGATIVE: No RBCs, no xanthochromia
                  • EQUIVOCAL: RBCs clearing, no xanthochromia (may need CTA)
                  1. Warning

                    LP Positive for SAH

                    SAH confirmed

                  2. Action

                    LP Negative

                    SAH unlikely

                    • No RBCs, no xanthochromia
                    • Consider alternative diagnoses
                    • Migraine, tension headache
                    • Cervical artery dissection (consider CTA if suspicious)
                    1. Outcome

                      Discharge with Precautions

                      SAH ruled out

                      • Headache treatment
                      • Strict return precautions
                      • Return if: Worse headache, fever, neuro symptoms
                      • Primary care follow-up

Guideline Source

ACEP Clinical Policy: Evaluation of Adult Patients with Suspected SAH + AHA/ASA SAH Guidelines 2023

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Ottawa SAH Rule requires validation
  • LP timing after CT varies by practice
  • CTA sensitivity depends on aneurysm size
  • Does not cover traumatic SAH management

Contraindicated Populations

pediatric

Applicable Regions

USEUGlobal

US: ACEP 2019 + AHA 2023 combined

Version 1Next review: 2027-01-01

Frequently Asked Questions

What is the Subarachnoid Hemorrhage Evaluation (ACEP 2019 + AHA 2023)?

The Subarachnoid Hemorrhage Evaluation (ACEP 2019 + AHA 2023) is a emergency clinical algorithm for Emergency Medicine. It provides a structured decision tree to guide clinical decision-making, based on ACEP Clinical Policy: Evaluation of Adult Patients with Suspected SAH + AHA/ASA SAH Guidelines 2023.

What guideline is the Subarachnoid Hemorrhage Evaluation (ACEP 2019 + AHA 2023) based on?

This algorithm is based on ACEP Clinical Policy: Evaluation of Adult Patients with Suspected SAH + AHA/ASA SAH Guidelines 2023 (DOI: 10.1016/j.annemergmed.2019.02.001).

What are the limitations of the Subarachnoid Hemorrhage Evaluation (ACEP 2019 + AHA 2023)?

Known limitations include: Ottawa SAH Rule requires validation; LP timing after CT varies by practice; CTA sensitivity depends on aneurysm size; Does not cover traumatic SAH management. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Subarachnoid Hemorrhage Evaluation (ACEP 2019 + AHA 2023) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free